These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15131000)

  • 1. The complexities of the cardiovascular actions of cannabinoids.
    Randall MD; Kendall DA; O'Sullivan S
    Br J Pharmacol; 2004 May; 142(1):20-6. PubMed ID: 15131000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of cannabinoids.
    Randall MD; Harris D; Kendall DA; Ralevic V
    Pharmacol Ther; 2002 Aug; 95(2):191-202. PubMed ID: 12182966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of endocannabinoids--the plot thickens.
    Kunos G; Járai Z; Varga K; Liu J; Wang L; Wagner JA
    Prostaglandins Other Lipid Mediat; 2000 Apr; 61(1-2):71-84. PubMed ID: 10785543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoids: a new class of vasoactive substances.
    Randall MD; Kendall DA
    Trends Pharmacol Sci; 1998 Feb; 19(2):55-8. PubMed ID: 9550942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoids as cardiovascular modulators.
    Kunos G; Járai Z; Bátkai S; Goparaju SK; Ishac EJ; Liu J; Wang L; Wagner JA
    Chem Phys Lipids; 2000 Nov; 108(1-2):159-68. PubMed ID: 11106789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quest for a vascular endothelial cannabinoid receptor.
    Kunos G; Bátkai S; Offertáler L; Mo F; Liu J; Karcher J; Harvey-White J
    Chem Phys Lipids; 2002 Dec; 121(1-2):45-56. PubMed ID: 12505689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E; Martín MI; López-Miranda V
    Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function.
    Ralevic V; Kendall DA; Randall MD; Smart D
    Life Sci; 2002 Oct; 71(22):2577-94. PubMed ID: 12354577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?
    Hiley CR; Hoi PM
    Cardiovasc Drug Rev; 2007; 25(1):46-60. PubMed ID: 17445087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery.
    Randall MD; Kendall DA
    Eur J Pharmacol; 1998 Apr; 346(1):51-3. PubMed ID: 9617751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular pharmacology of anandamide.
    Högestätt ED; Zygmunt PM
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):343-51. PubMed ID: 12052048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An endogenous cannabinoid as an endothelium-derived vasorelaxant.
    Randall MD; Alexander SP; Bennett T; Boyd EA; Fry JR; Gardiner SM; Kemp PA; McCulloch AI; Kendall DA
    Biochem Biophys Res Commun; 1996 Dec; 229(1):114-20. PubMed ID: 8954092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries.
    Plane F; Holland M; Waldron GJ; Garland CJ; Boyle JP
    Br J Pharmacol; 1997 Aug; 121(8):1509-11. PubMed ID: 9283682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endothelium-derived hyperpolarizing factor].
    Brăiloiu C; Beşchea-Chiriac C; Chiriac M
    Rev Med Chir Soc Med Nat Iasi; 1998; 102(3-4):49-55. PubMed ID: 10756843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids: new targets for drug development.
    Di Marzo ; Bisogno T; De Petrocellis L
    Curr Pharm Des; 2000 Sep; 6(13):1361-80. PubMed ID: 10903398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.
    O'Sullivan SE; Kendall DA; Randall MD
    Br J Pharmacol; 2004 Jun; 142(3):435-42. PubMed ID: 15148250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoids in the central nervous system--an overview.
    Fride E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenously produced cannabinoids and liver cirrhosis.
    Senior K
    Lancet; 2001 Jul; 358(9275):42. PubMed ID: 11454385
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
    Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
    J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids biology: the search for new therapeutic targets.
    Felder CC; Dickason-Chesterfield AK; Moore SA
    Mol Interv; 2006 Jun; 6(3):149-61. PubMed ID: 16809476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.